Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

Pharmaceutical Market

Pharmaceutical News

Pharmaceutical Stocks

Pharmaceutical Market
Pharmaceutical News
Pharmaceutical Stocks

Applied Therapeutics

NSD:APLT

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need.

Featured Articles and Interviews

Mar 10, 2025

Sci-Fi Meets Reality: Lab-Grown Organs, Woolly Mice and 3D-Printed Hearts Redefining Life Sciences

Feb 11, 2025

What is In-Licensing?

Jan 23, 2025

5 US Longevity and Anti-aging Stocks to Watch in 2025

More Featured Articles and Inverviews

Press Releases

More Press Releases

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart.

Go Deeper

AI Powered

Interactive Chart

Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.